P3 Health Partners Inc.
PIII · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $1,500 | $1,266 | $1,049 | $637 |
| % Growth | 18.5% | 20.7% | 64.7% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $668 |
| Gross Profit | $1,500 | $1,266 | $1,049 | -$31 |
| % Margin | 100% | 100% | 100% | -4.8% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $113 | $122 | $157 | $0 |
| SG&A Expenses | $114 | $126 | $162 | $157 |
| Sales & Mktg Exp. | $1 | $3 | $5 | $0 |
| Other Operating Expenses | $1,707 | $1,309 | $2,448 | $0 |
| Operating Expenses | $1,821 | $1,434 | $2,610 | $157 |
| Operating Income | -$321 | -$168 | -$1,561 | -$188 |
| % Margin | -21.4% | -13.3% | -148.7% | -29.5% |
| Other Income/Exp. Net | $15 | -$16 | $1 | -$16 |
| Pre-Tax Income | -$306 | -$184 | -$1,560 | -$204 |
| Tax Expense | $4 | $3 | $2 | $0 |
| Net Income | -$136 | -$58 | -$270 | -$156 |
| % Margin | -9.1% | -4.6% | -25.7% | -24.6% |
| EPS | -46.79 | -30.443 | -324.836 | -188.174 |
| % Growth | -53.7% | 90.6% | -72.6% | – |
| EPS Diluted | -54.06 | -30.443 | -324.836 | -188.174 |
| Weighted Avg Shares Out | 3 | 2 | 1 | 1 |
| Weighted Avg Shares Out Dil | 3 | 2 | 1 | 1 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $22 | $16 | $11 | $11 |
| Depreciation & Amortization | $86 | $87 | $87 | $9 |
| EBITDA | -$198 | -$81 | -$1,461 | -$185 |
| % Margin | -13.2% | -6.4% | -139.2% | -29% |